{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:59:28Z","timestamp":1791910768718,"version":"4.3.4"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T00:00:00Z","timestamp":1684540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T00:00:00Z","timestamp":1684540800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003715","name":"Korea Research Institute of Bioscience and Biotechnology","doi-asserted-by":"publisher","award":["KGM4572121"],"award-info":[{"award-number":["KGM4572121"]}],"id":[{"id":"10.13039\/501100003715","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003569","name":"Ministry of Food and Drug Safety","doi-asserted-by":"publisher","award":["22203MFDS404"],"award-info":[{"award-number":["22203MFDS404"]}],"id":[{"id":"10.13039\/501100003569","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2022M3E5F1016595"],"award-info":[{"award-number":["2022M3E5F1016595"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003669","name":"Korea Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["2020-ER5303-00"],"award-info":[{"award-number":["2020-ER5303-00"]}],"id":[{"id":"10.13039\/501100003669","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Severe fever\u00a0with\u00a0thrombocytopenia\u00a0syndrome virus was first discovered in 2009 as the causative agent of severe fever with thrombocytopenia syndrome. Despite its potential threat to public health, no prophylactic vaccine is yet available. This study developed a heterologous prime-boost strategy comprising priming with recombinant replication-deficient human adenovirus type 5 (rAd5) expressing the surface glycoprotein, Gn, and boosting with Gn protein. This vaccination regimen induced balanced Th1\/Th2 immune responses and resulted in potent humoral and T cell-mediated responses in mice. It elicited high neutralizing antibody titers in both mice and non-human primates. Transcriptome analysis revealed that rAd5 and Gn proteins induced adaptive and innate immune pathways, respectively. This study provides immunological and mechanistic insight into this heterologous regimen and paves the way for future strategies against emerging infectious diseases.<\/jats:p>","DOI":"10.1038\/s41598-023-35328-9","type":"journal-article","created":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T09:01:49Z","timestamp":1684573309000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Heterologous vaccination utilizing viral vector and protein platforms confers complete protection against SFTSV"],"prefix":"10.1038","volume":"13","author":[{"given":"Jae-Yong","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyeongseok","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Joo","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-In","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyeonggon","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyo-Jung","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye Won","family":"Kwak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyeong-Jun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoo-Jin","family":"Bang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Sun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seo-Hyeon","family":"Bae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"So-Hee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung-Ah","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dae-Im","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seong Hoo","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Hwan","family":"Seo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Green","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanseul","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hwal-Yong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ki Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee-Young","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pyeonghwa","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joo-Yeon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junho","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Myeong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hae Li","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manki","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nam-Hyuk","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-suk","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"So-Hee","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Hwan","family":"Nam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,20]]},"reference":[{"key":"35328_CR1","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1002\/rmv.1776","volume":"24","author":"S Liu","year":"2014","unstructured":"Liu, S. et al. Systematic review of severe fever with thrombocytopenia syndrome: Virology, epidemiology, and clinical characteristics. Rev. Med. Virol. 24, 90\u2013102. https:\/\/doi.org\/10.1002\/rmv.1776 (2014).","journal-title":"Rev. Med. Virol."},{"key":"35328_CR2","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/s41541-020-00257-5","volume":"5","author":"NE Bopp","year":"2020","unstructured":"Bopp, N. E. et al. Baseline mapping of severe fever with thrombocytopenia syndrome virology, epidemiology and vaccine research and development. NPJ Vaccines 5, 111. https:\/\/doi.org\/10.1038\/s41541-020-00257-5 (2020).","journal-title":"NPJ Vaccines"},{"key":"35328_CR3","doi-asserted-by":"publisher","first-page":"e1007375","DOI":"10.1371\/journal.ppat.1007375","volume":"15","author":"KH Kim","year":"2019","unstructured":"Kim, K. H. et al. An anti-Gn glycoprotein antibody from a convalescent patient potently inhibits the infection of severe fever with thrombocytopenia syndrome virus. PLoS Pathog 15, e1007375. https:\/\/doi.org\/10.1371\/journal.ppat.1007375 (2019).","journal-title":"PLoS Pathog"},{"key":"35328_CR4","doi-asserted-by":"publisher","first-page":"E7564","DOI":"10.1073\/pnas.1705176114","volume":"114","author":"Y Wu","year":"2017","unstructured":"Wu, Y. et al. Structures of phlebovirus glycoprotein Gn and identification of a neutralizing antibody epitope. Proc. Natl. Acad. Sci. U. S. A. 114, E7564\u2013E7573. https:\/\/doi.org\/10.1073\/pnas.1705176114 (2017).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"35328_CR5","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/s12276-021-00610-1","volume":"53","author":"MA Casel","year":"2021","unstructured":"Casel, M. A., Park, S. J. & Choi, Y. K. Severe fever with thrombocytopenia syndrome virus: Emerging novel phlebovirus and their control strategy. Exp. Mol. Med. 53, 713\u2013722. https:\/\/doi.org\/10.1038\/s12276-021-00610-1 (2021).","journal-title":"Exp. Mol. Med."},{"key":"35328_CR6","doi-asserted-by":"publisher","first-page":"43","DOI":"10.7774\/cevr.2018.7.1.43","volume":"7","author":"NJC Robles","year":"2018","unstructured":"Robles, N. J. C., Han, H. J., Park, S. J. & Choi, Y. K. Epidemiology of severe fever and thrombocytopenia syndrome virus infection and the need for therapeutics for the prevention. Clin. Exp. Vaccine Res. 7, 43\u201350. https:\/\/doi.org\/10.7774\/cevr.2018.7.1.43 (2018).","journal-title":"Clin. Exp. Vaccine Res."},{"key":"35328_CR7","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1056\/NEJMoa1203378","volume":"367","author":"LK McMullan","year":"2012","unstructured":"McMullan, L. K. et al. A new phlebovirus associated with severe febrile illness in Missouri. N. Engl. J. Med. 367, 834\u2013841. https:\/\/doi.org\/10.1056\/NEJMoa1203378 (2012).","journal-title":"N. Engl. J. Med."},{"key":"35328_CR8","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.cmi.2015.03.001","volume":"21","author":"DX Li","year":"2015","unstructured":"Li, D. X. Severe fever with thrombocytopenia syndrome: A newly discovered emerging infectious disease. Clin. Microbiol. Infect. 21, 614\u2013620. https:\/\/doi.org\/10.1016\/j.cmi.2015.03.001 (2015).","journal-title":"Clin. Microbiol. Infect."},{"key":"35328_CR9","unstructured":"World Health Organization, Annual review of diseases prioritized under the Research and Development Blueprint (2018)"},{"key":"35328_CR10","doi-asserted-by":"publisher","first-page":"167","DOI":"10.4049\/jimmunol.204.Supp.167.33","volume":"204","author":"JE Kwak","year":"2020","unstructured":"Kwak, J. E. et al. Development of a DNA vaccine for SFTSV that confers complete protection against lethal infection in ferrets. J. Immunol. 204, 167\u2013233 (2020).","journal-title":"J. Immunol."},{"key":"35328_CR11","doi-asserted-by":"publisher","first-page":"e0007813","DOI":"10.1371\/journal.pntd.0007813","volume":"14","author":"JG Kang","year":"2020","unstructured":"Kang, J. G. et al. Vaccination with single plasmid DNA encoding IL-12 and antigens of severe fever with thrombocytopenia syndrome virus elicits complete protection in IFNAR knockout mice. PLoS Negl. Trop. Dis. 14, e0007813. https:\/\/doi.org\/10.1371\/journal.pntd.0007813 (2020).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"35328_CR12","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.3389\/fmicb.2020.01473","volume":"11","author":"Z Zhao","year":"2020","unstructured":"Zhao, Z. et al. Recombinant human adenovirus type 5 co-expressing RABV G and SFTSV Gn induces protective immunity against rabies virus and severe fever with thrombocytopenia syndrome virus in mice. Front Microbiol. 11, 1473. https:\/\/doi.org\/10.3389\/fmicb.2020.01473 (2020).","journal-title":"Front Microbiol."},{"key":"35328_CR13","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.actbio.2018.08.033","volume":"80","author":"J Lee","year":"2018","unstructured":"Lee, J., Arun Kumar, S., Jhan, Y. Y. & Bishop, C. J. Engineering DNA vaccines against infectious diseases. Acta Biomater. 80, 31\u201347. https:\/\/doi.org\/10.1016\/j.actbio.2018.08.033 (2018).","journal-title":"Acta Biomater."},{"key":"35328_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19113605","author":"D Hobernik","year":"2018","unstructured":"Hobernik, D. & Bros, M. DNA vaccines-how far from clinical use?. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms19113605 (2018).","journal-title":"Int. J. Mol. Sci."},{"key":"35328_CR15","doi-asserted-by":"publisher","first-page":"11981","DOI":"10.1038\/s41598-021-91445-3","volume":"11","author":"Y-J Bang","year":"2021","unstructured":"Bang, Y.-J. et al. Effective inactivated influenza vaccine for the elderly using a single-stranded RNA-based adjuvant. Sci. Rep. 11, 11981. https:\/\/doi.org\/10.1038\/s41598-021-91445-3 (2021).","journal-title":"Sci. Rep."},{"key":"35328_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics12050441","author":"HJ Kim","year":"2020","unstructured":"Kim, H. J. et al. MERS-CoV spike protein vaccine and inactivated influenza vaccine formulated with single strand RNA adjuvant induce T-cell activation through intranasal immunization in mice. Pharmaceutics https:\/\/doi.org\/10.3390\/pharmaceutics12050441 (2020).","journal-title":"Pharmaceutics"},{"key":"35328_CR17","doi-asserted-by":"publisher","first-page":"5191","DOI":"10.1016\/j.vaccine.2019.07.070","volume":"37","author":"HW Kwak","year":"2019","unstructured":"Kwak, H. W. et al. Cricket paralysis virus internal ribosome entry site-derived RNA promotes conventional vaccine efficacy by enhancing a balanced Th1\/Th2 response. Vaccine 37, 5191\u20135202. https:\/\/doi.org\/10.1016\/j.vaccine.2019.07.070 (2019).","journal-title":"Vaccine"},{"key":"35328_CR18","doi-asserted-by":"publisher","first-page":"3468","DOI":"10.1016\/j.vaccine.2018.04.082","volume":"36","author":"SY Jung","year":"2018","unstructured":"Jung, S. Y. et al. Heterologous prime-boost vaccination with adenoviral vector and protein nanoparticles induces both Th1 and Th2 responses against Middle East respiratory syndrome coronavirus. Vaccine 36, 3468\u20133476. https:\/\/doi.org\/10.1016\/j.vaccine.2018.04.082 (2018).","journal-title":"Vaccine"},{"key":"35328_CR19","doi-asserted-by":"publisher","first-page":"e50447","DOI":"10.1371\/journal.pone.0050447","volume":"7","author":"G Betts","year":"2012","unstructured":"Betts, G. et al. Optimising immunogenicity with viral vectors: mixing MVA and HAdV-5 expressing the mycobacterial antigen Ag85A in a single injection. PLoS ONE 7, e50447. https:\/\/doi.org\/10.1371\/journal.pone.0050447 (2012).","journal-title":"PLoS ONE"},{"key":"35328_CR20","doi-asserted-by":"publisher","first-page":"e67123","DOI":"10.1371\/journal.pone.0067123","volume":"8","author":"TM Lawrence","year":"2013","unstructured":"Lawrence, T. M. et al. Comparison of heterologous prime-boost strategies against human immunodeficiency virus type 1 gag using negative stranded RNA viruses. PLoS ONE 8, e67123. https:\/\/doi.org\/10.1371\/journal.pone.0067123 (2013).","journal-title":"PLoS ONE"},{"key":"35328_CR21","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.coi.2009.05.016","volume":"21","author":"S Lu","year":"2009","unstructured":"Lu, S. Heterologous prime-boost vaccination. Curr. Opin. Immunol. 21, 346\u2013351. https:\/\/doi.org\/10.1016\/j.coi.2009.05.016 (2009).","journal-title":"Curr. Opin. Immunol."},{"key":"35328_CR22","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1128\/IAI.01410-13","volume":"82","author":"LH Teixeira","year":"2014","unstructured":"Teixeira, L. H. et al. Immunogenicity of a prime-boost vaccine containing the circumsporozoite proteins of Plasmodium vivax in rodents. Infect. Immun. 82, 793\u2013807. https:\/\/doi.org\/10.1128\/IAI.01410-13 (2014).","journal-title":"Infect. Immun."},{"key":"35328_CR23","doi-asserted-by":"publisher","first-page":"280","DOI":"10.4014\/jmb.1410.10035","volume":"25","author":"E Yang","year":"2015","unstructured":"Yang, E. et al. Protection of mice against pandemic H1N1 influenza virus challenge after immunization with baculovirus-expressed stabilizing peptide fusion hemagglutinin protein. J. Microbiol. Biotechnol. 25, 280\u2013287. https:\/\/doi.org\/10.4014\/jmb.1410.10035 (2015).","journal-title":"J. Microbiol. Biotechnol."},{"key":"35328_CR24","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s42826-020-00070-0","volume":"36","author":"S-C Park","year":"2020","unstructured":"Park, S.-C. et al. Pathogenicity of severe fever with thrombocytopenia syndrome virus in mice regulated in type I interferon signaling. Lab. Anim. Res. 36, 38. https:\/\/doi.org\/10.1186\/s42826-020-00070-0 (2020).","journal-title":"Lab. Anim. Res."},{"key":"35328_CR25","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.1923","volume":"9","author":"B Langmead","year":"2012","unstructured":"Langmead, B. & Salzberg, S. L. Fast gapped-read alignment with Bowtie 2. Nat. Methods 9, 357\u2013359. https:\/\/doi.org\/10.1038\/nmeth.1923 (2012).","journal-title":"Nat. Methods"},{"key":"35328_CR26","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1007\/s00335-015-9583-x","volume":"26","author":"JM Mudge","year":"2015","unstructured":"Mudge, J. M. & Harrow, J. Creating reference gene annotation for the mouse C57BL6\/J genome assembly. Mamm. Genome 26, 366\u2013378. https:\/\/doi.org\/10.1007\/s00335-015-9583-x (2015).","journal-title":"Mamm. Genome"},{"key":"35328_CR27","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","volume":"30","author":"Y Liao","year":"2014","unstructured":"Liao, Y., Smyth, G. K. & Shi, W. featureCounts: An efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics 30, 923\u2013930. https:\/\/doi.org\/10.1093\/bioinformatics\/btt656 (2014).","journal-title":"Bioinformatics"},{"key":"35328_CR28","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol 15, 550. https:\/\/doi.org\/10.1186\/s13059-014-0550-8 (2014).","journal-title":"Genome Biol"},{"key":"35328_CR29","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/s41587-019-0114-2","volume":"37","author":"AM Newman","year":"2019","unstructured":"Newman, A. M. et al. Determining cell type abundance and expression from bulk tissues with digital cytometry. Nat. Biotechnol. 37, 773\u2013782. https:\/\/doi.org\/10.1038\/s41587-019-0114-2 (2019).","journal-title":"Nat. Biotechnol."},{"key":"35328_CR30","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/s41592-019-0456-1","volume":"16","author":"W Mao","year":"2019","unstructured":"Mao, W., Zaslavsky, E., Hartmann, B. M., Sealfon, S. C. & Chikina, M. Pathway-level information extractor (PLIER) for gene expression data. Nat. Methods 16, 607\u2013610. https:\/\/doi.org\/10.1038\/s41592-019-0456-1 (2019).","journal-title":"Nat. Methods"},{"key":"35328_CR31","doi-asserted-by":"publisher","first-page":"D545","DOI":"10.1093\/nar\/gkaa970","volume":"49","author":"M Kanehisa","year":"2021","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Ishiguro-Watanabe, M. & Tanabe, M. KEGG: Integrating viruses and cellular organisms. Nucleic Acids Res 49, D545\u2013D551. https:\/\/doi.org\/10.1093\/nar\/gkaa970 (2021).","journal-title":"Nucleic Acids Res"},{"key":"35328_CR32","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1128\/CVI.00222-13","volume":"20","author":"X Guo","year":"2013","unstructured":"Guo, X. et al. Human antibody neutralizes severe Fever with thrombocytopenia syndrome virus, an emerging hemorrhagic Fever virus. Clin. Vaccine Immunol. 20, 1426\u20131432. https:\/\/doi.org\/10.1128\/CVI.00222-13 (2013).","journal-title":"Clin. Vaccine Immunol."},{"key":"35328_CR33","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1111\/j.0818-9641.2004.01272.x","volume":"82","author":"N Petrovsky","year":"2004","unstructured":"Petrovsky, N. & Aguilar, J. C. Vaccine adjuvants: current state and future trends. Immunol. Cell Biol. 82, 488\u2013496. https:\/\/doi.org\/10.1111\/j.0818-9641.2004.01272.x (2004).","journal-title":"Immunol. Cell Biol."},{"key":"35328_CR34","doi-asserted-by":"publisher","first-page":"11540","DOI":"10.1002\/anie.202002979","volume":"59","author":"HJ Park","year":"2020","unstructured":"Park, H. J. et al. Nanoformulated single-stranded RNA-based adjuvant with a coordinative amphiphile as an effective stabilizer: Inducing humoral immune response by activation of antigen-presenting cells. Angew. Chem. Int. Ed. Engl. 59, 11540\u201311549. https:\/\/doi.org\/10.1002\/anie.202002979 (2020).","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"35328_CR35","doi-asserted-by":"publisher","first-page":"6141","DOI":"10.1016\/j.vaccine.2020.07.022","volume":"38","author":"YH Kim","year":"2020","unstructured":"Kim, Y. H. et al. Inactivated influenza vaccine formulated with single-stranded RNA-based adjuvant confers mucosal immunity and cross-protection against influenza virus infection. Vaccine 38, 6141\u20136152. https:\/\/doi.org\/10.1016\/j.vaccine.2020.07.022 (2020).","journal-title":"Vaccine"},{"key":"35328_CR36","doi-asserted-by":"publisher","first-page":"26494","DOI":"10.1038\/srep26494","volume":"6","author":"SE Bentebibel","year":"2016","unstructured":"Bentebibel, S. E. et al. ICOS(+)PD-1(+)CXCR3(+) T follicular helper cells contribute to the generation of high-avidity antibodies following influenza vaccination. Sci. Rep. 6, 26494. https:\/\/doi.org\/10.1038\/srep26494 (2016).","journal-title":"Sci. Rep."},{"key":"35328_CR37","doi-asserted-by":"publisher","first-page":"176ra132","DOI":"10.1126\/scitranslmed.3005191","volume":"5","author":"SE Bentebibel","year":"2013","unstructured":"Bentebibel, S. E. et al. Induction of ICOS+CXCR3+CXCR5+ TH cells correlates with antibody responses to influenza vaccination. Sci. Transl. Med. 5, 176ra132. https:\/\/doi.org\/10.1126\/scitranslmed.3005191 (2013).","journal-title":"Sci. Transl. Med."},{"key":"35328_CR38","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.immuni.2013.09.007","volume":"39","author":"J He","year":"2013","unstructured":"He, J. et al. Circulating precursor CCR7(lo)PD-1(hi) CXCR5(+) CD4(+) T cells indicate Tfh cell activity and promote antibody responses upon antigen reexposure. Immunity 39, 770\u2013781. https:\/\/doi.org\/10.1016\/j.immuni.2013.09.007 (2013).","journal-title":"Immunity"},{"key":"35328_CR39","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s42826-020-00070-0","volume":"36","author":"SC Park","year":"2020","unstructured":"Park, S. C. et al. Pathogenicity of severe fever with thrombocytopenia syndrome virus in mice regulated in type I interferon signaling: Severe fever with thrombocytopenia and type I interferon. Lab. Anim. Res. 36, 38. https:\/\/doi.org\/10.1186\/s42826-020-00070-0 (2020).","journal-title":"Lab. Anim. Res."},{"key":"35328_CR40","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1172\/jci97611","volume":"128","author":"PJ Chockley","year":"2018","unstructured":"Chockley, P. J. et al. Epithelial-mesenchymal transition leads to NK cell-mediated metastasis-specific immunosurveillance in lung cancer. J. Clin. Invest. 128, 1384\u20131396. https:\/\/doi.org\/10.1172\/jci97611 (2018).","journal-title":"J. Clin. Invest."},{"key":"35328_CR41","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/s41571-022-00610-8","volume":"19","author":"A Fendler","year":"2022","unstructured":"Fendler, A. et al. COVID-19 vaccines in patients with cancer: Immunogenicity, efficacy and safety. Nat. Rev. Clin. Oncol. 19, 385\u2013401. https:\/\/doi.org\/10.1038\/s41571-022-00610-8 (2022).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"35328_CR42","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12979-019-0164-9","volume":"16","author":"SN Crooke","year":"2019","unstructured":"Crooke, S. N., Ovsyannikova, I. G., Poland, G. A. & Kennedy, R. B. Immunosenescence and human vaccine immune responses. Immun. Age. 16, 25. https:\/\/doi.org\/10.1186\/s12979-019-0164-9 (2019).","journal-title":"Immun. Age."},{"key":"35328_CR43","doi-asserted-by":"publisher","first-page":"14024","DOI":"10.1096\/fj.202001413R","volume":"34","author":"M Reithofer","year":"2020","unstructured":"Reithofer, M. et al. Alum triggers infiltration of human neutrophils ex vivo and causes lysosomal destabilization and mitochondrial membrane potential-dependent NET-formation. FASEB J. 34, 14024\u201314041. https:\/\/doi.org\/10.1096\/fj.202001413R (2020).","journal-title":"FASEB J."},{"key":"35328_CR44","doi-asserted-by":"publisher","first-page":"W296","DOI":"10.1093\/nar\/gky427","volume":"46","author":"A Waterhouse","year":"2018","unstructured":"Waterhouse, A. et al. SWISS-MODEL: Homology modelling of protein structures and complexes. Nucleic Acids Res 46, W296\u2013W303. https:\/\/doi.org\/10.1093\/nar\/gky427 (2018).","journal-title":"Nucleic Acids Res"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-35328-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-35328-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-35328-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T09:05:38Z","timestamp":1684573538000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-35328-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,20]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["35328"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-35328-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2420776\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,20]]},"assertion":[{"value":"28 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8189"}}